KR880005120A - 불안해소제 및 우울증 치료제로서의 가교된 비사이클릭 이미드 - Google Patents

불안해소제 및 우울증 치료제로서의 가교된 비사이클릭 이미드 Download PDF

Info

Publication number
KR880005120A
KR880005120A KR870011634A KR870011634A KR880005120A KR 880005120 A KR880005120 A KR 880005120A KR 870011634 A KR870011634 A KR 870011634A KR 870011634 A KR870011634 A KR 870011634A KR 880005120 A KR880005120 A KR 880005120A
Authority
KR
South Korea
Prior art keywords
compound
crosslinked bicyclic
anxiolytics
antidepressants
crosslinked
Prior art date
Application number
KR870011634A
Other languages
English (en)
Other versions
KR900000565B1 (ko
Inventor
마이클 브라이트 진
Original Assignee
알렌 제이. 스피겔
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알렌 제이. 스피겔, 화이자 인코포레이티드 filed Critical 알렌 제이. 스피겔
Publication of KR880005120A publication Critical patent/KR880005120A/ko
Application granted granted Critical
Publication of KR900000565B1 publication Critical patent/KR900000565B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

내용 없음

Description

불안해소제 및 우울증 치료제로서의 가교된 비사이클릭 이미드
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 다음 일반식 (I)의 가교 결합된 비사이클릭 이미드 화합물 및 그의 약제학적으로 허용되는 산-부가염.
    [일반식 I]
    상기식에서 R1및 R2는 각각 H 또는 CH3이고 : R3는 H 또는 F이며 : (a) X는 CH2· CH2CH2또는CH2CH2CH2이고 : Y는 CH2·CH(CH3)· CH(CH3)2· C(CH2)4또는 CH2CH2이거나 : (b) X는 CH=CH· CH2CH(CH3) 또는 CH2C(CH3)2이고: Y는 CH2이다.
  2. 제1항에 있어서, R3가 H이고 : X가 CH2·CH2CH2또는 CH2CH2CH2이며 : X가 CH2·C(CH2)2·C(CH2)4또는 CH2CH2인 화합물.
  3. 제2항에 있어서, X가 CH1CH 인 화합물.
  4. 제3항에 있어서, R1및 R2가 각각 H이고 Y가 CH2인 화합물.
  5. 제3항에 있어서, R1이 CH3이고 R2가 H이며 Y가 C(CH3)2인 화합물.
  6. 제5항에 있어서, 3-(4-[4-(2-피리미디닐)-1-피페라지닐]부틸)-1,8,8-트리메틸-3-아자비사이클로[3,2,1]옥탄-2,4-디온의 우회전성 이성체인 화합물.
  7. 제1항에 있어서, R1이 CH3이고 R2가 H이며, R3가 F이고, X가 CH2CH2이며 Y가 C(CH3)2인 화합물.
  8. 제1항에 있어서, R3가H이고 : X가 CH=CH· CH2CH(CHx) 또는 CH2C(CH3)2이며 : Y가 CH2인화합물.
  9. 제8항에 있어서, R1및 R2가 각각 H이고 X가 CH2CH(CH3)인 화합물.
  10. 약제학적으로 허용되는 담체 및 제1항에 따르는 가교된 비사이클릭 아미드 화합물로 이루어진 약제학적 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870011634A 1986-10-21 1987-10-20 불안해소제 및 우울증 치료제로서의 가교된 비사이클릭 이미드 KR900000565B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
USPCT/US86/02224 1986-10-21
US02224 1986-10-21
PCT/US1986/002224 WO1988003024A1 (en) 1986-10-21 1986-10-21 Bridged bicyclic imides as anxiolytics and antidepressants

Publications (2)

Publication Number Publication Date
KR880005120A true KR880005120A (ko) 1988-06-28
KR900000565B1 KR900000565B1 (ko) 1990-01-31

Family

ID=22195680

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870011634A KR900000565B1 (ko) 1986-10-21 1987-10-20 불안해소제 및 우울증 치료제로서의 가교된 비사이클릭 이미드

Country Status (26)

Country Link
EP (1) EP0268369B1 (ko)
JP (1) JPS63112581A (ko)
KR (1) KR900000565B1 (ko)
CN (1) CN1015987B (ko)
AT (1) ATE66222T1 (ko)
AU (1) AU579963B2 (ko)
DD (1) DD263531A5 (ko)
DE (1) DE3772158D1 (ko)
DK (1) DK547487A (ko)
EG (1) EG18718A (ko)
ES (1) ES2031517T3 (ko)
FI (1) FI90775C (ko)
GR (1) GR3002483T3 (ko)
HU (1) HU198203B (ko)
IE (1) IE60378B1 (ko)
IL (1) IL84206A (ko)
MX (1) MX8898A (ko)
MY (1) MY101833A (ko)
NO (1) NO882715L (ko)
NZ (1) NZ222229A (ko)
PH (1) PH23806A (ko)
PL (1) PL149172B1 (ko)
PT (1) PT85944B (ko)
WO (1) WO1988003024A1 (ko)
YU (1) YU45461B (ko)
ZA (1) ZA877863B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748240A (en) * 1987-04-03 1988-05-31 American Home Products Corporation Psychotropic bicyclic imides
US4810789A (en) * 1987-08-28 1989-03-07 Bristol-Myers Company Process for buspirone hydrochloride polymorphic crystalline form conversion
WO1990002552A1 (en) * 1988-09-16 1990-03-22 Pfizer Inc. Antipsychotic 4-[4-(3-benzisothiazolyl)-1-piperazinyl]butyl bridged bicyclic imides
SU1825501A3 (ru) * 1990-10-29 1995-12-10 И.В. Комиссаров Dl-3-[(4-[4- (2-пиридил)-1- пиперазинил]бутил)] -1,8,8-триметил -3-азабицикло[3,2,1] октан-2,4-диона дигидрохлорид, проявляющий противотревожную, нейролептическую и противорвотную активность
CN101906107B (zh) * 2010-08-02 2012-12-26 南京林业大学 一种由α-蒎烯合成樟脑酸酐的方法
EP3610890A1 (en) 2012-11-14 2020-02-19 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006233A (en) * 1974-10-04 1977-02-01 Merck & Co., Inc. N-(pyrimidinyl)-tricyclo[3(or 4).2.2.02,4(or 5) ]-non (or dec)ene-dicarboximides
US4173646A (en) * 1974-10-04 1979-11-06 Merck & Co., Inc. Tricyclicdicarboximides
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US4562255A (en) * 1984-03-30 1985-12-31 American Home Products Corporation Substituted bi-alicyclic imides
JPS61238784A (ja) * 1985-04-17 1986-10-24 Sumitomo Seiyaku Kk コハク酸イミド誘導体及びその酸付加塩
DE3529872A1 (de) * 1985-08-21 1987-02-26 Kali Chemie Pharma Gmbh Neue tetraoxoverbindungen

Also Published As

Publication number Publication date
MX8898A (es) 1993-10-01
YU192087A (en) 1988-10-31
DK547487D0 (da) 1987-10-20
HU198203B (en) 1989-08-28
FI90775C (fi) 1994-03-25
ES2031517T3 (es) 1992-12-16
FI882942A (fi) 1988-06-20
IL84206A (en) 1992-07-15
DD263531A5 (de) 1989-01-04
AU579963B2 (en) 1988-12-15
CN87107107A (zh) 1988-05-04
MY101833A (en) 1992-01-31
EP0268369A1 (en) 1988-05-25
JPS63112581A (ja) 1988-05-17
PL268296A1 (en) 1988-08-18
EP0268369B1 (en) 1991-08-14
WO1988003024A1 (en) 1988-05-05
HUT47270A (en) 1989-02-28
PH23806A (en) 1989-11-23
JPH0448792B2 (ko) 1992-08-07
NO882715D0 (no) 1988-06-20
ZA877863B (en) 1989-06-28
ATE66222T1 (de) 1991-08-15
PL149172B1 (en) 1990-01-31
AU7994687A (en) 1988-04-28
DE3772158D1 (de) 1991-09-19
GR3002483T3 (en) 1992-12-30
IL84206A0 (en) 1988-03-31
FI882942A0 (fi) 1988-06-20
FI90775B (fi) 1993-12-15
IE872835L (en) 1988-04-21
PT85944A (en) 1987-11-01
NO882715L (no) 1988-06-20
PT85944B (pt) 1990-07-31
KR900000565B1 (ko) 1990-01-31
NZ222229A (en) 1989-12-21
YU45461B (en) 1992-05-28
EG18718A (en) 1993-12-30
IE60378B1 (en) 1994-07-13
CN1015987B (zh) 1992-03-25
DK547487A (da) 1988-04-22

Similar Documents

Publication Publication Date Title
DE3888854D1 (de) Neue tricyclische Benzimidazole, Verfahren zu ihrer Herstellung und Verwendung als Arzneimittel.
SE8600174D0 (sv) Nytt forfarande for framstellning av n-(2-pyrimidinyl)-piperazinylalkylazaspiroalkandioner
DK0474712T3 (da) Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat
DE3779825D1 (de) Derivate von benzhydryloxyaethylpiperazinen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2038623T3 (es) Procedimiento para preparar soluciones de oxazafosforinas con estabilidad mejorada.
KR880005120A (ko) 불안해소제 및 우울증 치료제로서의 가교된 비사이클릭 이미드
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
ATE139441T1 (de) Verwendung von 2-iminothiazolidin-4-onderivaten als neuartige arzneimittelwirkstoffe
DK520787A (da) Terapeutisk middel indeholdende propentofyllin eller derivater deraf til brug ved behandling af peptisk ulcus
DK149199C (da) Analogifremgangsmaade til fremstilling af hexahydro-1,4-oxazepiner eller salte deraf dannet med fysiologisk acceptable syrer
BE1002181A3 (fr) 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines, de meme que le traitement de la leucemie et des tumeurs avec ces substances.
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
ATE5480T1 (de) Thiazolo(3,2-a)pyrimidinderivate, ihre herstellung und arzneimittel, die diese derivate enthalten.
DE3862660D1 (de) 2,3-dihydro-2-oxo-3-benzofuranyl-essigsaeurederivate und diese enthaltende arzneimittel.
ATE81125T1 (de) Benzimidazol-2-one-derivate, deren salze, verfahren und zwischenprodukte zu deren herstellung, deren anwendung als arzneimittel und sie enthaltende zusammensetzungen.
ATE97130T1 (de) 13-brom und 13, 14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln.
DE68919438D1 (de) Alpha-adrenergische Rezeptorantagonisten.
KR870006898A (ko) 신장염 치료제
DE68917217D1 (de) Alpha-adrenergische Rezeptorantagonisten.

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19931210

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee